Leerink Partners analyst Andrew Berens maintained a Hold rating on Elevation Oncology (ELEV – Research Report) on April 16. The company’s ...

UnitedHealth has traditionally been a company investors saw as reliable, having not missed earnings estimates since the 2008 global financial crisis.

UnitedHealth Group’s stock dropped sharply on Thursday after the insurance giant slashed its earnings outlook for 2025. The announcement led to a broad drop in the Dow Jones Industrial Average, ...

UnitedHealth Group stock had one of its worst days ever on Thursday after the healthcare giant unexpectedly cut its profit ...

Pulled lower by UnitedHealth Group’s ( UNH) paring back of its forecasts for 2025—the news left the giant’s shares down ...

A surprising Medicare Advantage cost spike helped push UnitedHealth into a rare deep dive Thursday, after the health care ...

The UnitedHealth slide weighed heavily on the Dow, which fell 527 points, or 1.3%.

The stock fell as much as 20%, dragging industry peers Humana and CVS lower as well.

The surprising news that UnitedHealth Group lowered its 2025 profit forecast shocked Wall Street but the company still made ...

The Dow Jones Industrial Average (DJIA) declined on Thursday despite many stocks on the index rising. Instead, a few major ...

We recently published a list of the 10 Innovative Healthcare Stocks to Watch in 2025. In this article, we are going to take a ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.